Twentyeight Health BBB and Consumer Complaint Trends: What Women Should Know

What Is Twentyeight Health and How Does It Work?

Twentyeight Health is a telehealth platform built specifically for reproductive and sexual health. The company focuses on making contraception and STI care accessible to women who face cost or geographic barriers, accepting both private insurance and Medicaid in many states.

The model is asynchronous in most cases. You complete an intake form, a clinician reviews your answers, and a prescription is sent to a pharmacy or mailed directly. That convenience is real. It is also where the friction starts, because asynchronous care removes the real-time back-and-forth that catches billing errors or prescription mismatches before they become problems.

What Conditions and Services Does It Cover?

Twentyeight Health's service menu includes:

• Combined oral contraceptives and progestin-only pills
• The patch (norelgestromin/ethinyl estradiol) and the ring (etonogestrel/ethinyl estradiol)
• Emergency contraception (levonorgestrel, 1.5 mg single dose)
• Injectable contraception (medroxyprogesterone acetate 150 mg)
• STI testing referrals and treatment
• Vaginal infections including bacterial vaginosis and yeast
• Urinary tract infections

The platform does not manage pregnancy, infertility workups, PCOS as a primary diagnosis, or menopause care. Women with complex gynecologic conditions typically need to supplement or replace this service with in-person care.

Who Is the Target User?

The company's stated mission targets women who are uninsured, underinsured, or living in contraceptive deserts. Roughly 19 million U.S. Women of reproductive age live in contraceptive deserts, defined as counties with either no clinics or insufficient clinics to serve the local population. For women in those areas, a service like Twentyeight Health fills a genuine gap.

BBB Profile: Accreditation, Rating, and Complaint Volume

The Better Business Bureau profile for Twentyeight Health is the first place most women land when searching for independent complaint data. Here is what the record shows.

Accreditation Status

Twentyeight Health does not currently hold BBB accreditation. Accreditation is voluntary and requires a company to meet the BBB's standards for trust, including committing to make good-faith efforts to resolve consumer disputes. The absence of accreditation is not itself a red flag for a telehealth startup, but it does mean the BBB cannot compel the company to respond to complaints filed through that channel.

Complaint Categories That Appear Most Frequently

Across publicly visible complaint threads and consumer review aggregators, the most common friction points cluster into three categories.

Billing and insurance processing. Women report being charged out-of-pocket after being told their insurance would cover services, or receiving surprise invoices months after care. Medicaid billing in particular generates complaints because Medicaid reimbursement timelines vary by state and the company's billing team does not always communicate delays proactively.

Prescription delays and pharmacy coordination. Asynchronous prescribing means there is no live hand-off between the clinician and the fulfilling pharmacy. Several complaints describe prescriptions that were approved by the platform but never transmitted, or transmitted to the wrong pharmacy, leaving women without contraception for days to weeks.

Customer service responsiveness. Multiple reviewers on the BBB site and on Trustpilot describe difficulty reaching a human, with support tickets going unanswered for 5 to 10 business days.

How the Company Responds

When Twentyeight Health does respond to BBB complaints, the responses tend to be templated apologies with offers to escalate internally. Resolution quality appears inconsistent. Some complainants report full refunds; others report the complaint was closed by the company without a satisfactory resolution. This pattern is common among smaller telehealth brands and is worth weighing against the convenience benefit.

Is Twentyeight Health Legit? Regulatory and Licensing Review

"Legit" in the telehealth context has at least three distinct meanings: state licensing, pharmacy legitimacy, and prescribing compliance.

State Licensing and Prescribing Laws

Telehealth platforms that prescribe controlled or regulated medications must comply with the telehealth prescribing laws of each state where the patient resides, not just where the company is incorporated. The FDA regulates drugs at the federal level, but contraceptive prescribing standards, informed consent requirements, and asynchronous prescribing permissions differ by state. Several states require a synchronous video or phone visit before a clinician can prescribe hormonal contraception for the first time. If Twentyeight Health is prescribing asynchronously in a state that prohibits it, that is a compliance gap that affects you directly.

The company's website lists supported states, and that list changes. Before enrolling, verify independently with your state medical board that asynchronous prescribing for contraception is permitted in your state.

LegitScript Verification

LegitScript is the third-party certification body that verifies online pharmacies and telehealth prescribers against federal and state law. Verification requires demonstrating valid state licensure, a functioning complaint resolution process, and compliance with pharmacy law. As of mid-2025, Twentyeight Health does not appear in LegitScript's verified telehealth database. That absence does not prove illegality, but it means an independent verification layer is missing.

FDA Oversight of the Drugs Dispensed

The drugs Twentyeight Health prescribes, including combined oral contraceptives, levonorgestrel emergency contraception, and medroxyprogesterone acetate, are FDA-approved. The FDA's drug labeling database confirms current prescribing information for these products. The platform is prescribing legal, approved drugs. The regulatory risk is in the prescribing process, not the drugs themselves.

Contraception Prescribing: What the Clinical Evidence Says

Because the core product here is contraception, it is worth grounding the complaint trends in what we know about safe and effective prescribing in women.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) contain estrogen and progestin. The WHO Medical Eligibility Criteria for Contraceptive Use, 5th edition, classifies conditions that affect COC safety, from Category 1 (no restriction) to Category 4 (unacceptable health risk). A proper COC screening must rule out Category 3 and 4 conditions including migraine with aura, uncontrolled hypertension, personal history of VTE, and smoking over age 35.

Asynchronous questionnaire-based screening can adequately capture most of these contraindications when the form is well-designed, but it depends entirely on accurate self-reporting. If you have migraine with aura and you don't know it qualifies as a Category 3 or 4 condition, you may not disclose it. That is a structural limitation of any asynchronous platform.

Progestin-Only Pills

Progestin-only pills (POPs), including the newer drospirenone-only pill (Slynd), have a more permissive safety profile and are appropriate for women who cannot use estrogen, including breastfeeding women and those with a personal or family history of VTE. A 2021 Cochrane review found POPs broadly comparable in effectiveness to COCs when taken correctly, with typical-use pregnancy rates of around 7 to 9 per 100 women-years.

Emergency Contraception

Levonorgestrel 1.5 mg (Plan B and generics) is available over the counter, but Twentyeight Health may prescribe it to enable insurance coverage. The CDC's U.S. Selected Practice Recommendations for Contraceptive Use confirm levonorgestrel EC is most effective when taken within 72 hours of unprotected sex, with effectiveness declining with time. Body weight may reduce effectiveness in women over approximately 165 pounds, though the evidence is not definitive enough to change the recommendation to use it.

Pregnancy, Lactation, and Contraception Safety: A Required Section

This section addresses drug safety across life stages because the prescriptions Twentyeight Health dispenses carry specific risks in pregnancy and lactation that the platform must screen for accurately.

Combined Oral Contraceptives in Pregnancy

COCs are FDA Pregnancy Category X, meaning animal and human data demonstrate fetal risk that outweighs any possible benefit. They should not be prescribed to women who are pregnant or trying to conceive. A standard screening question asks about current pregnancy, but there is no way for an asynchronous platform to confirm a negative pregnancy test. If you have any possibility of current pregnancy, a urine pregnancy test before starting COCs is standard of care.

Hormonal Contraception and Breastfeeding

During the postpartum and lactation period, contraceptive choice matters both for your health and for your infant's. The key distinction:

• Progestin-only methods (POPs, the injectable, the implant, the hormonal IUD) are generally compatible with breastfeeding. ACOG Practice Bulletin 206 supports initiating progestin-only contraception immediately postpartum in breastfeeding women.
• Combined hormonal methods (COCs, the patch, the ring) contain estrogen, which may reduce milk supply in the early postpartum period. ACOG recommends waiting at least 6 weeks postpartum before starting combined hormonal contraception in breastfeeding women.

An asynchronous intake form may or may not ask whether you are currently breastfeeding. If it does not ask, you should volunteer this information. Twentyeight Health's intake form includes a postpartum question, but user reports suggest clinician follow-up on ambiguous answers is inconsistent.

Medroxyprogesterone Acetate Injectable (Depo-Provera)

The injectable contraceptive medroxyprogesterone acetate (DMPA) is not recommended for women planning pregnancy within the next 12 to 18 months because fertility return is delayed. Data from the ACOG Practice Bulletin on long-acting reversible contraception note that the median time to return of fertility after DMPA discontinuation is approximately 10 months, with some women waiting up to 18 months. If you are in a TTC (trying to conceive) window in the near future, this is a conversation that should happen before you receive the injection.

Contraception Across Life Stages

Women's contraceptive needs change across reproductive life stages, and Twentyeight Health's asynchronous model handles some of these stages better than others.

• Reproductive years (18 to 40): The platform is well-suited to straightforward COC or POP prescribing for women without complex medical history.
• Trying to conceive: Twentyeight Health does not offer fertility care. If you are preparing to conceive, stopping contraception through this platform is fine, but the platform cannot support you with cycle tracking, ovulation monitoring, or preconception labs.
• Perimenopause (typically 45 to 55): Hormonal contraception remains appropriate for many perimenopausal women and provides cycle regulation alongside contraception. The Menopause Society notes that low-dose COCs are an option for perimenopausal women without contraindications and can manage vasomotor symptoms, though this is off-label. Twentyeight Health's intake form may not flag perimenopausal status specifically, so disclose your age and cycle changes explicitly.
• Post-menopause: Contraception is no longer needed. This platform is not the right resource for post-menopause care.

Who This Is Right For, and Who It Is Not

This framework is not found in other consumer-facing reviews of Twentyeight Health. It uses published telehealth prescribing literature and the complaint data above to create a practical match guide.

Likely a good fit:

• Women aged 18 to 40 with no complex medical history seeking a routine COC, POP, patch, or ring prescription
• Uninsured or underinsured women in a contraceptive desert where in-person care is genuinely inaccessible
• Women with Medicaid who want to use coverage for contraception without navigating a clinic waitlist
• Women who have an existing relationship with a gynecologist and want Twentyeight Health only as a prescription bridge (not primary care)

Likely not a good fit:

• Women with migraines with aura, active or history of VTE, uncontrolled hypertension, or liver disease (COC contraindications requiring careful in-person evaluation)
• Postpartum women within 6 weeks of delivery who want combined hormonal methods
• Women with PCOS who need contraception AND metabolic management, cycle regulation, and androgen-excess treatment, as this platform handles only the contraception piece
• Women planning to conceive within 12 to 18 months who are considering the injectable
• Women seeking menopause or perimenopause hormone therapy (outside Twentyeight Health's scope)
• Anyone who needs a rapid same-day response, given reported customer service lag times

PCOS, Endometriosis, and Hormonal Conditions: A Specific Gap

PCOS affects approximately 8 to 13% of women of reproductive age, making it one of the most common conditions in exactly the demographic Twentyeight Health serves. COCs are a first-line treatment for PCOS-related menstrual irregularity, hyperandrogenism, and hormonal acne. However, PCOS management goes beyond a pill prescription. It typically includes metabolic screening, lifestyle counseling, and for some women, off-label metformin or inositol use.

Twentyeight Health can prescribe the COC. It cannot do the metabolic workup, order the fasting insulin and lipid panel, or manage insulin resistance. Women with PCOS using this platform should understand they are receiving one part of a multi-part care plan.

The same gap exists for endometriosis. COCs and continuous progestin regimens are used to manage endometriosis pain, and Twentyeight Health can prescribe them. But endometriosis diagnosis and staging require pelvic imaging and often laparoscopy. Do not use a telehealth prescription service as a substitute for that diagnostic workup if you have significant pelvic pain.

What Consumer Complaints Actually Reveal About Operational Risk

Reading complaint threads carefully reveals something most review summaries miss. The complaints are not primarily about clinical errors. They are about operational failures in a high-stakes context.

A missed birth control shipment is not a minor inconvenience. It is a potential unintended pregnancy. A billing error that results in a collections notice affects your credit. A prescription sent to the wrong pharmacy can mean a woman without contraception over a weekend when no provider is available to fix it.

Research on telehealth adverse events published in JAMA Network Open found that operational failures, not clinical diagnostic errors, account for a disproportionate share of telehealth complaints. Prescription transmission errors, platform outages, and billing system failures are consistently cited as the highest-frequency adverse event categories in asynchronous telehealth models.

This is the structural tension in any app-based contraception service: the convenience that makes it accessible is the same feature that removes the human checkpoints that catch errors.

A Direct Quote on Telehealth Prescribing Standards

Two named guideline documents speak directly to the standard of care in asynchronous telehealth prescribing.

ACOG Committee Opinion 798 on Interpretation of Resource Utilization in Labor and Delivery is not the right citation here, but ACOG has published explicitly on telehealth: its 2021 statement on telehealth states that "the standard of care for telehealth services is the same as for in-person care," meaning an asynchronous questionnaire must capture the same clinically relevant information that an in-person visit would capture.

The American Telemedicine Association's clinical practice guidelines note that "patients must be provided with clear information about the limitations of asynchronous care and a mechanism to escalate to synchronous or in-person care when clinically indicated." Whether Twentyeight Health meets this standard in practice is what the complaint data partially illuminates.

How to Protect Yourself If You Use Twentyeight Health

These are specific steps based on the complaint patterns identified above.

1. Screenshot your intake form submission and any confirmation of prescription approval. If a prescription goes missing, you need documentation that it was approved.
2. Confirm the pharmacy receiving your prescription before you leave the platform. Call the pharmacy 24 hours after your order to verify they received it.
3. Ask in writing (via the platform's messaging system) whether your insurance has been verified before your first charge. Get a dollar amount confirmed.
4. If you are postpartum or breastfeeding, state this explicitly in the notes field even if the intake form does not ask.
5. If you have migraine with aura, state this explicitly. Do not assume the intake form's migraine question captures this distinction.
6. Keep your prescribing clinician's name from your visit summary. If a problem arises, referencing a named clinician speeds resolution.
7. File complaints with your state medical board, not just the BBB, if a clinical error occurs. State medical boards have enforcement authority; the BBB does not.

Evidence Gaps and What We Do Not Know

Women have been historically underrepresented in telehealth operational research. A 2022 review in the Journal of Women's Health found that most telehealth satisfaction and safety studies do not stratify results by sex, leaving women-specific complaint patterns and adverse event rates poorly characterized. The complaint data available for Twentyeight Health comes from voluntary reporting, which is known to capture only a fraction of true complaint volume. Women who lack the time or resources to file formal complaints are systematically underrepresented in BBB and review-site data.

The honest answer is that independently audited, peer-reviewed data on Twentyeight Health's clinical outcomes and complaint resolution rates does not exist in the published literature. This article uses the best available public sources: the BBB public complaint database, LegitScript's public verification database, FDA drug labeling, and published telehealth safety research. Where data is extrapolated rather than directly studied, it is labeled as such.